Could patients glean stock tips?: Drug trial participants may be insider trading.

Could patients glean stock tips?: Drug trial participants may be insider trading.
“Patients in clinical trials might be using information about the drug they are taking to trade illegally in pharmaceutical stocks, warns a group of doctors and bioethicists. But they have no idea how prevalent the problem might be.”

Click here for reuse options!
Copyright 2004 Biotechblog

Leave a Reply

%d bloggers like this: